There is a new clinical imperative to treat 38 million people with obstructive sleep apnea. That’s big business for device companies, if only they can access patients and establish new referral patter
by Mary Stuart At the very end of 2007, Philips Healthcare (a division of Royal Philips Electronics NV ) made a bold move, acquiring Philips Respironics for $5.1 billion in cash, to gain, th
Emulating the pancreas with a device to control blood sugar The majority of type I diabetics currently have only one treatment option—insulin injections. But, short of monitoring glucose every half ho